Member Info for fali41

Did a dummy sell they would take 10k shares at 249. Wowzer! They are accumulating for a push up today. Expect sellers from other covid fallers to buy in here today with the expectation of a quick 10-20%, so could see us move fast and then a retrace around 270-280.

Even though sells outweigh buys. Vatel must be on fumes on now surely, a strady pick up once they clear and we can be at 300p by Friday.

This could be the day that many predicted.

With progression as far as it is with the other tests, the market needs to accept we are still firmly in the drivers seat and supplying worldwide to countries like india, pakistan who are said to be weeks away from peak and Saudi Arabia who declared a potential second wave with a spike in cases. Our sales are not slowing down and the market cap is looking pathetic now. Wake up oh market!!

MMM - that is a strangely familar sounding theory. If see a rise tommorow then i suspect you may have hit the nail on the head.

Hats off tedoby - that is a great post.

GPM is 50-80%. NPM could be between 15-40%

£70k avg c. £3. With my investors hat on i have strong faith we will see true value eventually. Really felt £3 was the bottom a few weeks ago and was expecting the news to last week to drive us onwards. Therefore took profits from elsewhere and averaged down. The beauty of hindsight eh! Everything i sold to get a better average here has seen a minimum 20% increase since!

Good entry Frank- your courage looks as if it due to be rewarded.

Between 236-240. Seems as though the selling has dried up since this morning. Should start to climb from this level imo.

Buying volume has started to tick up and a few delayed trades coming through. This could be the bottom and now see a steady move up into the afternoon. Feeling rather sick watching this whilst the recovery plays fly on up!

Ive experienced two takeover offer from shares i have been invested in and on both occasions the price was ridiculously low and even though the offer was over double the SP at that time the company rejected both times as they felt the offer was undervaluing the company. I would suspect if a offer came in for £5 it would be pushed back as that is too low a valuation with current forecasts.

Just catching up with the weekend posts also. Some good stuff from the usual reliable posters and then a bit of rumbling in between by you know who. Looking forward to a better week and hopefully some nice suprised in terms of updates. Good luck all genuine holders!

Thanks parkez - interesting to see what develops of is..

So why has there not been any notification of their holding considering how significant it is? If doesnt fall within french law thats understanable but does that also mean they dont need to notify us as that law would take precedence?

Fair point Brod but i think this market would have been the one they would have tried to tap into from the off. Hence the announcement in March. If they havent managed to make successful inroads since March then i would be very concerned especially considering the amount of testing going on over there. I think Graham has purposely remained very tight lipped on any sort of progress but kept reminding us in the updates that they are pleased with progress over there, almost like subtle hints. Heck! I dont know tbh im a holder and remain optimistic but it could be nothing significant like you say. Lets just sit and hope. Would appreciate any updates from experienced researchers about about other clues available on this?

The most likely reason is that we dont own the rights and therefore cannot disclose until the US OEM announces there sales and then breakdown what cut novacyt are recieving.

https://microgenbioproducts.com/pathflow/

Is this the new Exaig test?

Can anyone give anymore insight into the signficance of the Novacyt link with Optigene. It is clear from the government constantly name dropping Optigene that they will be proceeding with this new test as part of the test, track and trace program. In line with recent developments it seems the trial for the lamp test is due to end at roughly the same time we are expected to go live on the track and trace, circa end of June.

I know that NCYT (primers) and Optigene (LAMP master mixers ) have worked together on this but does anyone have any idea if this is conclusive and that we are definetley involved and the potential benefit financially of being involved?

I appreciate our CEO liking posts from Dr Kidd ( Optigene) on linkedin is very reassuring but just wondered if there was anything else anyone knew? Also, i take it this involvement is seperate to the Exsig direct test we are due to launch or could this be the new test linked with optigene? Theres quite a few unknowns at present, hoping someone can shed some more light on.

Finally, What do people think about a potential acquisition of Optigene as an option also? Benefits, drawbacks, considering our financial position.

Fair play, i must admit i was worrried it was being dragged down further today!